Proteomic Evaluation of the Natural History of the Acute Radiation Syndrome of the Gastrointestinal Tract in a Non-human Primate Model of Partial-body Irradiation with Minimal Bone Marrow Sparing Includes Dysregulation of the Retinoid Pathway. 2020

Weiliang Huang, and Jianshi Yu, and Tian Liu, and Gregory Tudor, and Amy E Defnet, and Stephanie Zalesak, and Praveen Kumar, and Catherine Booth, and Ann M Farese, and Thomas J MacVittie, and Maureen A Kane
University of Maryland, School of Pharmacy, Department of Pharmaceutical Sciences, Baltimore, MD.

Exposure to ionizing radiation results in injuries of the hematopoietic, gastrointestinal, and respiratory systems, which are the leading causes responsible for morbidity and mortality. Gastrointestinal injury occurs as an acute radiation syndrome. To help inform on the natural history of the radiation-induced injury of the partial body irradiation model, we quantitatively profiled the proteome of jejunum from non-human primates following 12 Gy partial body irradiation with 2.5% bone marrow sparing over a time period of 3 wk. Jejunum was analyzed by liquid chromatography-tandem mass spectrometry, and pathway and gene ontology analysis were performed. A total of 3,245 unique proteins were quantified out of more than 3,700 proteins identified in this study. Also a total of 289 proteins of the quantified proteins showed significant and consistent responses across at least three time points post-irradiation, of which 263 proteins showed strong upregulations while 26 proteins showed downregulations. Bioinformatic analysis suggests significant pathway and upstream regulator perturbations post-high dose irradiation and shed light on underlying mechanisms of radiation damage. Canonical pathways altered by radiation included GP6 signaling pathway, acute phase response signaling, LXR/RXR activation, and intrinsic prothrombin activation pathway. Additionally, we observed dysregulation of proteins of the retinoid pathway and retinoic acid, an active metabolite of vitamin A, as quantified by liquid chromatography-tandem mass spectrometry. Correlation of changes in protein abundance with a well-characterized histological endpoint, corrected crypt number, was used to evaluate biomarker potential. These data further define the natural history of the gastrointestinal acute radiation syndrome in a non-human primate model of partial body irradiation with minimal bone marrow sparing.

UI MeSH Term Description Entries
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D008297 Male Males
D011829 Radiation Dosage The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv). Sievert Units,Dosage, Radiation,Gray Units,Gy Radiation,Sv Radiation Dose Equivalent,Dosages, Radiation,Radiation Dosages,Units, Gray,Units, Sievert
D011833 Radiation Injuries, Experimental Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals. Experimental Radiation Injuries,Injuries, Experimental Radiation,Experimental Radiation Injury,Radiation Injury, Experimental
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000069079 Radiation Exposure Phenomenon in which organisms are subjected to radiation. Exposure, Radiation
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012176 Retinoids A group of tetraterpenes, with four terpene units joined head-to-tail. Biologically active members of this class are used clinically in the treatment of severe cystic ACNE; PSORIASIS; and other disorders of keratinization. Retinoid
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Weiliang Huang, and Jianshi Yu, and Tian Liu, and Gregory Tudor, and Amy E Defnet, and Stephanie Zalesak, and Praveen Kumar, and Catherine Booth, and Ann M Farese, and Thomas J MacVittie, and Maureen A Kane
December 2017, Radiation research,
Weiliang Huang, and Jianshi Yu, and Tian Liu, and Gregory Tudor, and Amy E Defnet, and Stephanie Zalesak, and Praveen Kumar, and Catherine Booth, and Ann M Farese, and Thomas J MacVittie, and Maureen A Kane
November 2020, Health physics,
Weiliang Huang, and Jianshi Yu, and Tian Liu, and Gregory Tudor, and Amy E Defnet, and Stephanie Zalesak, and Praveen Kumar, and Catherine Booth, and Ann M Farese, and Thomas J MacVittie, and Maureen A Kane
March 2019, Health physics,
Weiliang Huang, and Jianshi Yu, and Tian Liu, and Gregory Tudor, and Amy E Defnet, and Stephanie Zalesak, and Praveen Kumar, and Catherine Booth, and Ann M Farese, and Thomas J MacVittie, and Maureen A Kane
October 2021, Health physics,
Weiliang Huang, and Jianshi Yu, and Tian Liu, and Gregory Tudor, and Amy E Defnet, and Stephanie Zalesak, and Praveen Kumar, and Catherine Booth, and Ann M Farese, and Thomas J MacVittie, and Maureen A Kane
March 2019, Health physics,
Weiliang Huang, and Jianshi Yu, and Tian Liu, and Gregory Tudor, and Amy E Defnet, and Stephanie Zalesak, and Praveen Kumar, and Catherine Booth, and Ann M Farese, and Thomas J MacVittie, and Maureen A Kane
December 2017, Radiation research,
Weiliang Huang, and Jianshi Yu, and Tian Liu, and Gregory Tudor, and Amy E Defnet, and Stephanie Zalesak, and Praveen Kumar, and Catherine Booth, and Ann M Farese, and Thomas J MacVittie, and Maureen A Kane
May 2019, Health physics,
Weiliang Huang, and Jianshi Yu, and Tian Liu, and Gregory Tudor, and Amy E Defnet, and Stephanie Zalesak, and Praveen Kumar, and Catherine Booth, and Ann M Farese, and Thomas J MacVittie, and Maureen A Kane
March 2019, Health physics,
Weiliang Huang, and Jianshi Yu, and Tian Liu, and Gregory Tudor, and Amy E Defnet, and Stephanie Zalesak, and Praveen Kumar, and Catherine Booth, and Ann M Farese, and Thomas J MacVittie, and Maureen A Kane
March 2019, Health physics,
Weiliang Huang, and Jianshi Yu, and Tian Liu, and Gregory Tudor, and Amy E Defnet, and Stephanie Zalesak, and Praveen Kumar, and Catherine Booth, and Ann M Farese, and Thomas J MacVittie, and Maureen A Kane
March 2019, Health physics,
Copied contents to your clipboard!